Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
orBec for gastrointestinal graft-versus-host disease
NCT00233896Phase 3Completed
- Sponsor
- Enteron Pharmaceuticals
- Start
- Jul 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing orBec Arm with Placebo Arm (2 arms). Primary endpoint: Treatment Failure by Day 50. Started Jul 2001; status: completed.
02
Drugs
beclomethasone dipropionate
Beyond the preview
Go deeper on NCT00233896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233896.